Narat Punyacharoensin1, William John Edmunds, Daniela De Angelis, Valerie Delpech, Graham Hart, Jonathan Elford, Alison Brown, Noel Gill, Richard G White. 1. aCentre for the Mathematical Modelling of Infectious Diseases and Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London bMedical Research Council Biostatistics Unit, Cambridge cHIV and STI Department, Public Health England, Colindale dCentre for Sexual Health & HIV Research, Department of Infection & Population Health, Mortimer Market Centre, University College London eSchool of Health Sciences, City University London, London, UK.
Abstract
OBJECTIVES: HIV is a major public health problem among MSM in the United Kingdom with around 2400 new infections annually. We quantified the contribution of biological and behavioural factors. DESIGN: Modelling study. METHODS: A partnership-based model of HIV transmission among UK MSM aged 15-64 years was developed and calibrated to time series HIV prevalence. The calibration was validated using multiple surveillance datasets. Population-attributable fractions were used to estimate the contribution of behavioural and biological factors to HIV transmission over the period 2001-2002, 2014-2015, and 2019-2020. RESULTS: The contribution of most biological and behavioural factors was relatively constant over time, with the key group sustaining HIV transmission being higher-sexual activity MSM aged below 35 years living with undiagnosed HIV. The effect of primary HIV infection was relatively small with 2014-2015 population-attributable fraction of 10% (3-28%) in comparison with other subsequent asymptomatic stages. Diagnosed men who were not on antiretroviral therapy (ART) currently contributed 26% (14-39%) of net infections, whereas ART-treated MSM accounted for 17% (10-24%). A considerable number of new infections are also likely to occur within long-term relationships. CONCLUSION: The majority of the new HIV infections among MSM in the United Kingdom during 2001-2020 is expected to be accounted for by a small group of younger and highly sexually active individuals, living with undiagnosed HIV in the asymptomatic stage. Bringing this group into HIV/AIDS care by improving testing uptake is a vital step for preventing onward transmission and will determine the success of using ART as prevention.
OBJECTIVES: HIV is a major public health problem among MSM in the United Kingdom with around 2400 new infections annually. We quantified the contribution of biological and behavioural factors. DESIGN: Modelling study. METHODS: A partnership-based model of HIV transmission among UK MSM aged 15-64 years was developed and calibrated to time series HIV prevalence. The calibration was validated using multiple surveillance datasets. Population-attributable fractions were used to estimate the contribution of behavioural and biological factors to HIV transmission over the period 2001-2002, 2014-2015, and 2019-2020. RESULTS: The contribution of most biological and behavioural factors was relatively constant over time, with the key group sustaining HIV transmission being higher-sexual activity MSM aged below 35 years living with undiagnosed HIV. The effect of primary HIV infection was relatively small with 2014-2015 population-attributable fraction of 10% (3-28%) in comparison with other subsequent asymptomatic stages. Diagnosed men who were not on antiretroviral therapy (ART) currently contributed 26% (14-39%) of net infections, whereas ART-treated MSM accounted for 17% (10-24%). A considerable number of new infections are also likely to occur within long-term relationships. CONCLUSION: The majority of the new HIV infections among MSM in the United Kingdom during 2001-2020 is expected to be accounted for by a small group of younger and highly sexually active individuals, living with undiagnosed HIV in the asymptomatic stage. Bringing this group into HIV/AIDS care by improving testing uptake is a vital step for preventing onward transmission and will determine the success of using ART as prevention.
Authors: Stéphane Le Vu; Oliver Ratmann; Valerie Delpech; Alison E Brown; O Noel Gill; Anna Tostevin; David Dunn; Christophe Fraser; Erik M Volz Journal: AIDS Res Hum Retroviruses Date: 2019-09 Impact factor: 2.205
Authors: Andrew N Phillips; Valentina Cambiano; Alec Miners; Fiona C Lampe; Alison Rodger; Fumiyo Nakagawa; Alison Brown; O Noel Gill; Daniela De Angelis; Jonathan Elford; Graham Hart; Anne M Johnson; Jens D Lundgren; Simon Collins; Valerie Delpech Journal: AIDS Date: 2015-09-10 Impact factor: 4.177
Authors: Nicky McCreesh; Ioannis Andrianakis; Rebecca N Nsubuga; Mark Strong; Ian Vernon; Trevelyan J McKinley; Jeremy E Oakley; Michael Goldstein; Richard Hayes; Richard G White Journal: BMC Infect Dis Date: 2017-08-09 Impact factor: 3.090
Authors: Juliana Maria Reyes-Urueña; Colin N J Campbell; Núria Vives; Anna Esteve; Juan Ambrosioni; Cristina Tural; Elena Ferrer; Gemma Navarro; Lluis Force; Isabel García; Àngels Masabeu; Josep M Vilaró; Patricia García de Olalla; Joan Artur Caylà; Josep M Miró; Jordi Casabona Journal: BMJ Open Date: 2018-02-28 Impact factor: 2.692
Authors: Martin Holt; Toby Lea; Jason Asselin; Margaret Hellard; Garrett Prestage; David Wilson; John de Wit; Mark Stoové Journal: J Int AIDS Soc Date: 2015-11-11 Impact factor: 5.396
Authors: Kevin P Delaney; Eli S Rosenberg; Michael R Kramer; Lance A Waller; Patrick S Sullivan Journal: Open Forum Infect Dis Date: 2015-10-20 Impact factor: 3.835